article thumbnail

Xifin Hires CFO, Marketing VP

socalTECH

San Diego-based XIFIN , a publisher of hosted revenue cycle management software for diagnostic laboratories, reported Tuesday that it has added two members to its executive staff. William Taylor as vice president of marketing. The company said it has hired Steve Zaniboni as chief financial officer and R.

Arcturus 100
article thumbnail

Bio Roundup: Alnylam’s Billions, COVID-19 Vaccines, Moma Debuts & More

Xconomy

The public markets are moving erratically, but Alnylam Pharmaceuticals showed this week that selling equity isn’t the only way for biotech companies to raise cash. Late last year Alnylam (NASDAQ: ALNY ) began exploring potential royalty deals for inclisiran, a drug that uses RNA interference to lower cholesterol.

Equity 84
article thumbnail

Bio Roundup: Biotech IPOs, Migraine Progress, Takeda Woos Shire & More

Xconomy

The strength of the IPO market is notable because the first quarter is typically the slowest time of the year for companies to go public, EY told Xconomy. The number of companies filing to go public in the U.S. Life science companies accounted for nearly one third of the quarter’s IPOs.